Dr. Tad Gorske is a licensed psychologist in Pennsylvania and is the Director of Outpatient Neuropsychology in the Division of Neuropsychology and Rehabilitation Psychology within the Department of Physical Medicine and Rehabilitation at the University Of Pittsburgh School Of Medicine.
Dr. Gorske specializes in the neuropsychological assessment of patients with traumatic and acquired brain injuries. He also has specializations in Addiction Medicine, dual diagnosis, and severe mental illness. He is the primary author, with co-author Dr. Steven Smith, of Collaborative Therapeutic Neuropsychological Assessment (CTNA). CTNA is a patient-centred method of providing feedback from neuropsychological assessment measures design to educate about neuropsychological concepts, enhance clinician-patient collaboration, and enhance motivation to follow through with treatment goals. Dr. Gorske has published in the areas of addiction, dual diagnosis, neuropsychology, and motivational interviewing.
Invited Workshop Abstract:
Dr. Alex Tröster is a Professor and Senior Scientist at Barrow Neurological Institute in Phoenix, Arizona, where he also serves as director of neuropsychology research at the Barrow Center for Neuromodulation.. He received his doctorate in clinical psychology and neuropsychology from the University of California, San Diego and San Diego State University.
Dr. Tröster’s current research interests include the role of the basal ganglia in cognition, neuropsychology of cognition and emotion in Parkinson’s disease and other movement disorders, and the neuropsychological and quality of life effects of deep brain stimulation and functional neurosurgery. Current projects include the characterization of memory and verbal fluency deficits in Parkinson’s disease and intraoperative stimulation to study the role of basal ganglia in expressive language and predict language changes after deep brain stimulation. Dr. Tröster was also a member of the Movement Disorder Society Task Force that formulated mild cognitive impairment criteria and assessment guidelines for Parkinson’s disease, and he is currently examining the role of MCI in outcomes of neuromodulation.
He is a past recipient of the National Academy of Neuropsychology’s early career achievement award, and that Academy’s award for scientific contributions to clinical neuropsychology. Dr. Tröster has edited a book on memory disorders and authored or co-authored more than 160 scientific and medical journal articles and numerous book chapters. He serves on the editorial boards of the journals Neuropsychology, Brain and Cognition, Journal of the International Neuropsychological Society, Archives of Clinical Neuropsychology, and Neuropsychology Review, and as a reviewer for more than 30 other scientific and medical journals. He has been an invited lecturer at meetings in Europe and Asia.
Dr. Tröster belongs to a number of professional societies, including the International Neuropsychological Society, the National Academy of Neuropsychology (fellow), the Movement Disorders Society, the American Psychological Association (fellow), and the American Academy of Neurology. He is Past President of the National Academy of Neuropsychology. He served as the co-chair of the National Academy of Neuropsychology’s Policy and Planning Committee and on the American Psychological Association’s Division of Clinical Neuropsychology Practice Advisory Committee and Scientific Advisory Committee. Dr. Tröster has served as the chair of the scientific program committee for the National Academy of Neuropsychology twice, and on several committees of the International Neuropsychological Society. He was a member of the National Institutes of Health Workgroup on Cognition and Emotion in Parkinson’s Disease and the Deep Brain Stimulation Consensus Group of the Movement Disorders Society and Congress of Neurosurgeons. He served on the Movement Disorder Society committees for the assessment of psychosis and the assessment of cognition, its Task Force on Mild Cognitive Impairment and on the Parkinson Study Group’s scientific review committee.
Dr. Troster has served as a consultant to several medical device companies, including Medtronic, ANS/St Jude and Boston Scientific, in the design, conduct, and evaluation of deep brain stimulation trials for movement disorders, epilepsy, and psychiatric disorders.